Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-04-05 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −180,000 $21.70 $3.9M 63,648
2017-04-05 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion · Stock Option −180,000 0
2017-04-05 KUEBLER CHRISTOPHER A Director Exercise or conversion +15,000 $8.37 $126K 50,500
2017-04-05 KUEBLER CHRISTOPHER A Director Sale −15,000 $21.88 $328K 35,500
2017-04-05 KUEBLER CHRISTOPHER A Director Exercise or conversion · Stock Option −15,000 0
2017-03-20 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +75,000 $11.34 $851K 130,637
2017-03-20 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +37,500 $7.21 $270K 168,137
2017-03-20 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −112,500 $19.69 $2.2M 55,637
2017-03-20 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion · Stock Option −75,000 0
2017-03-20 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion · Stock Option −37,500 0
2017-03-15 WHITFIELD ROY A Director Exercise or conversion +14,000 $8.37 $117K 98,000
2017-03-15 WHITFIELD ROY A Director Exercise or conversion · Stock Option −14,000 0
2017-03-14 CHESS ROBERT Director Exercise or conversion +5,000 $8.37 $42K 276,623
2017-03-14 CHESS ROBERT Director Sale −5,000 $15.41 $77K 271,623
2017-03-14 CHESS ROBERT Director Exercise or conversion · Stock Option −5,000 10,000
2017-03-03 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion +7,494 $6.34 $48K 76,764
2017-03-03 Labrucherie Gil M SVP & Chief Financial Officer Sale −7,494 $15.21 $114K 69,270
2017-03-03 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion +25,000 $9.24 $231K 94,270
2017-03-03 Labrucherie Gil M SVP & Chief Financial Officer Sale −25,000 $15.21 $380K 69,270
2017-03-03 Labrucherie Gil M SVP & Chief Financial Officer Exercise or conversion · Stock Option −7,494 0

Page 44 of 55 · 1,088 trades